Mendel Capital Management LLC Acquires 49 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mendel Capital Management LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,237 shares of the healthcare conglomerate’s stock after purchasing an additional 49 shares during the quarter. Mendel Capital Management LLC’s holdings in UnitedHealth Group were worth $651,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Moneta Group Investment Advisors LLC raised its position in UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares in the last quarter. Norges Bank acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at $5,210,004,000. Arrowstreet Capital Limited Partnership grew its stake in shares of UnitedHealth Group by 1,682.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after acquiring an additional 2,540,538 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock valued at $1,238,515,000 after acquiring an additional 2,348,107 shares in the last quarter. Finally, Barclays PLC grew its stake in shares of UnitedHealth Group by 143.4% in the second quarter. Barclays PLC now owns 3,494,100 shares of the healthcare conglomerate’s stock valued at $1,679,401,000 after acquiring an additional 2,058,829 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 1.8 %

NYSE:UNH traded down $8.25 during mid-day trading on Wednesday, hitting $451.47. 2,967,700 shares of the company’s stock were exchanged, compared to its average volume of 4,219,003. The company has a 50 day simple moving average of $496.26 and a 200-day simple moving average of $517.67. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The firm has a market capitalization of $416.22 billion, a P/E ratio of 18.93, a PEG ratio of 1.24 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. During the same quarter last year, the business earned $5.34 EPS. The company’s revenue was up 14.1% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.67%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Barclays assumed coverage on shares of UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target on the stock. Piper Sandler cut their price objective on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research report on Wednesday, January 17th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 29th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Three analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $576.48.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.